Medicine
Meclizine 50 mg tablet
Meclizine 50 mg tablet is a generic prescription medicine for oral use, made by 6 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C…
Key facts
- Active ingredient (INN)
- Meclizine
- Brand
- Sold under the generic name
- Strength
- 50 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 500 tablets, 90 tablets, 100 tablets and 12 more
- Manufacturers
- Aurobindo PharmaIndiaAvet PharmaceuticalsIndiaAmneal PharmaceuticalsAsclemedChartwell RXRising Pharma Holdings
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 12 February 2010
- Identifiers
- RxCUI 995624, 995666, 995686 +1DailyMed set ID 666dc4d8-7b16-4c3c-84e4-645548dbee68, e6a5df4b-5cbf-4a0c-b38a-f4509c9c17db, c9ddc39c-bc6b-42f1-8c5f-5aff2d79c4bd +3NDC 65162-444, 76420-799, 16571-662 +3Application ANDA201451, NDA010721, ANDA205136 +2
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 500 tablet in 1 bottle | 59651-809-05 | Aurobindo PharmaIndia | 14 September 2023 |
| 90 tablet in 1 bottle | 59651-809-90 | Aurobindo PharmaIndia | 14 September 2023 |
| 100 tablet in 1 bottle | 23155-943-01 | Avet PharmaceuticalsIndia | 25 June 2026 |
| 1000 tablet in 1 package | 23155-943-10 | Avet PharmaceuticalsIndia | 25 June 2026 |
| 30 tablet in 1 bottle | 65162-444-03 | Amneal Pharmaceuticals | 12 February 2010 |
| 100 tablet in 1 bottle | 65162-444-10 | Amneal Pharmaceuticals | 12 February 2010 |
| 1000 tablet in 1 bottle | 65162-444-11 | Amneal Pharmaceuticals | 12 February 2010 |
| 500 tablet in 1 bottle | 65162-444-50 | Amneal Pharmaceuticals | 12 February 2010 |
| 100 tablet in 1 blister pack | 65162-444-60 | Amneal Pharmaceuticals | 12 February 2010 |
| 60 tablet, film coated in 1 bottle | 62135-954-60 | Chartwell RX | 4 March 2025 |
| 100 tablet in 1 bottle | 16571-662-01 | Rising Pharma Holdings | 15 January 2020 |
| 100 tablet in 1 bottle | 76420-799-01 | Asclemed | 5 April 2024 |
| 30 tablet in 1 bottle | 76420-799-30 | Asclemed | 5 April 2024 |
| 60 tablet in 1 bottle | 76420-799-60 | Asclemed | 5 April 2024 |
| 90 tablet in 1 bottle | 76420-799-90 | Asclemed | 5 April 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 14 February 1957 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Meclizine
Clinical summary
Meclizine is an antiemetic indicated for the treatment of vertigo associated with diseases affecting the vestibular system in adults. It is available as tablets and chewable tablets for oral use. MedsAcross supplies Meclizine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MeclizineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Meclizine Hydrochloride prescribing information (Rising Pharma Holdings) · U.S. National Library of Medicine, DailyMed
Need Meclizine 50 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.